Distinct Fcγ receptors mediate the effect of serum amyloid P on neutrophil adhesion and fibrocyte differentiation

Journal of Immunology

Volumn 193, Issue 4, 2014, Pages 1701-1708

  Cox, Nehemiah ^a   Pilling, Darrell ^a   Gomer, Richard H ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; FC RECEPTOR; FC RECEPTOR IIA; FIBRONECTIN; PENTRAXIN; SERUM AMYLOID P;

ADULT; AMINO ACID SEQUENCE; ARTICLE; BINDING SITE; CELL DIFFERENTIATION; CONTROLLED STUDY; CRYSTAL STRUCTURE; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNOCOMPETENT CELL; LEUKOCYTE ADHERENCE; LUNG FIBROSIS; LUNG FUNCTION; MACROPHAGE; MONOCYTE; NEUTROPHIL; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; SITE DIRECTED MUTAGENESIS;

AMINO ACID SEQUENCE; ANTIBODIES, BLOCKING; BINDING SITES, ANTIBODY; CELL ADHESION; CELL DIFFERENTIATION; CELLS, CULTURED; FIBROBLASTS; FIBROSIS; HEK293 CELLS; HUMANS; IMMUNOGLOBULIN G; INFLAMMATION; MACROPHAGES; MONOCYTES; NEUTROPHILS; PHAGOCYTOSIS; PROTEIN ISOFORMS; RECEPTORS, IGG; SERUM AMYLOID P-COMPONENT;

EID: 84905969461     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1400281     Document Type: Article

References (49)

1. Wynn, T. A. 2004. Fibrotic disease and the T(H)1/T(H)2 paradigm. Nat. Rev. Immunol. 4: 583-594.
2. Schuppan, D., and Y. O. Kim. 2013. Evolving therapies for liver fibrosis. J. Clin. Invest. 123: 1887-1901.
3. Reilkoff, R. A., R. Bucala, and E. L. Herzog. 2011. Fibrocytes: emerging effector cells in chronic inflammation. Nat. Rev. Immunol. 11: 427-435.
4. du Bois, R. M., S. D. Nathan, L. Richeldi, M. I. Schwarz, and P. W. Noble. 2012. Idiopathic pulmonary fibrosis: lung function is a clinically meaningful endpoint for phase III trials. Am. J. Respir. Crit. Care Med. 186: 712-715.
5. Mantovani, A., S. Valentino, S. Gentile, A. Inforzato, B. Bottazzi, and C. Garlanda. 2013. The long pentraxin PTX3: a paradigm for humoral pattern recognition molecules. Ann. N. Y. Acad. Sci. 1285: 1-14.
6. Deban, L., S. Jaillon, C. Garlanda, B. Bottazzi, and A. Mantovani. 2011. Pentraxins in innate immunity: lessons from PTX3. Cell Tissue Res. 343: 237-249.
7. Deban, L., B. Bottazzi, C. Garlanda, Y. M. De la Torre, and A. Mantovani. 2009. Pentraxins: multifunctional proteins at the interface of innate immunity and inflammation. Biofactors 35: 138-145.
8. Peisajovich, A., L. Marnell, C. Mold, and T. W. Du Clos. 2008. C-reactive protein at the interface between innate immunity and inflammation. Expert Rev. Clin. Immunol. 4: 379-390.
9. Pilling, D., D. Roife, M. Wang, S. D. Ronkainen, J. R. Crawford, E. L. Travis, and R. H. Gomer. 2007. Reduction of bleomycin-induced pulmonary fibrosis by serum amyloid P. J. Immunol. 179: 4035-4044.
10. Haudek, S. B., Y. Xia, P. Huebener, J. M. Lee, S. Carlson, J. R. Crawford, D. Pilling, R. H. Gomer, J. Trial, N. G. Frangogiannis, and M. L. Entman. 2006. Bone marrow-derived fibroblast precursors mediate ischemic cardiomyopathy in mice. Proc. Natl. Acad. Sci. USA 103: 18284-18289.
11. Castaño, A. P., S. L. Lin, T. Surowy, B. T. Nowlin, S. A. Turlapati, T. Patel, A. Singh, S. Li, M. L. Lupher, Jr., and J. S. Duffield. 2009. Serum amyloid P inhibits fibrosis through Fc gamma R-dependent monocyte-macrophage regulation in vivo. Sci. Transl. Med. 1: 5ra13.
12. Maharjan, A. S., D. Roife, D. Brazill, and R. H. Gomer. 2013. Serum amyloid P inhibits granulocyte adhesion. Fibrogenesis Tissue Repair 6: 2.
13. Dillingh, M. R., B. Van Den Blink, M. Moerland, M. G. Van Dongen, M. Levi, A. Kleinjan, M. S. Wijsenbeek, M. L. Lupher, Jr., D. M. Harper, J. A. Getsy, et al. 2013. Recombinant human serum amyloid P in healthy volunteers and patients with pulmonary fibrosis. Pulm. Pharmacol. Ther. 26: 672-676.
14. Kolaczkowska, E., and P. Kubes. 2013. Neutrophil recruitment and function in health and inflammation. Nat. Rev. Immunol. 13: 159-175.
15. Amulic, B., C. Cazalet, G. L. Hayes, K. D. Metzler, and A. Zychlinsky. 2012. Neutrophil function: from mechanisms to disease. Annu. Rev. Immunol. 30: 459-489.
16. Takemasa, A., Y. Ishii, and T. Fukuda. 2012. A neutrophil elastase inhibitor prevents bleomycin-induced pulmonary fibrosis in mice. Eur. Respir. J. 40: 1475-1482.
17. Stibenz, D., M. Gräfe, N. Debus, M. Hasbach, I. Bahr, K. Graf, E. Fleck, U. Thanabalasingam, and C. Bührer. 2006. Binding of human serum amyloid P componentto L-selectin. Eur. J. Immunol. 36: 446-456.
18. Bucala, R., L. A. Spiegel, J. Chesney, M. Hogan, and A. Cerami. 1994. Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol. Med. 1: 71-81.
19. Gomer, R. H., D. Pilling, L. M. Kauvar, S. Ellsworth, S. D. Ronkainen, D. Roife, and S. C. Davis. 2009. A serum amyloid P-binding hydrogel speeds healing of partial thickness wounds in pigs. Wound Repair Regen. 17: 397-404.
20. Quan, T. E., S. E. Cowper, and R. Bucala. 2006. The role of circulating fibrocytes in fibrosis. Curr. Rheumatol. Rep. 8: 145-150.
21. Crawford, J. R., D. Pilling, and R. H. Gomer. 2012. FcgRI mediates serum amyloid P inhibition of fibrocyte differentiation. J. Leukoc. Biol. 92: 699-711.
22. Haudek, S. B., J. Trial, Y. Xia, D. Gupta, D. Pilling, and M. L. Entman. 2008. Fc receptor engagement mediates differentiation of cardiac fibroblast precursor cells. Proc. Natl. Acad. Sci. USA 105: 10179-10184.
23. Lu, J., L. L. Marnell, K. D. Marjon, C. Mold, T.W. Du Clos, and P. D. Sun. 2008. Structural recognition and functional activation of FcgammaR by innate pentraxins. Nature 456: 989-992.
24. Bharadwaj, D., C. Mold, E. Markham, and T. W. Du Clos. 2001. Serum amyloid P component binds to Fc gamma receptors and opsonizes particles for phagocytosis. J. Immunol. 166: 6735-6741.
25. Nimmerjahn, F., and J. V. Ravetch. 2008. Fcgamma receptors as regulators of immune responses. Nat. Rev. Immunol. 8: 34-47.
26. Lu, J., K. D. Marjon, L. L. Marnell, R. Wang, C. Mold, T. W. Du Clos, and P. Sun. 2011. Recognition and functional activation of the human IgA receptor (FcalphaRI) by C-reactive protein. Proc. Natl. Acad. Sci. USA 108: 4974-4979.
27. Mold, C., H. D. Gresham, and T. W. Du Clos. 2001. Serum amyloid P component and C-reactive protein mediate phagocytosis through murine Fc gamma Rs. J. Immunol. 166: 1200-1205.
28. Pilling, D., V. Vakil, and R. H. Gomer. 2009. Improved serum-free culture conditions for the differentiation of human and murine fibrocytes. J. Immunol. Methods 351: 62-70.
29. Cox, N., D. Pilling, and R. H. Gomer. 2012. NaCl potentiates human fibrocyte differentiation. PLoS ONE 7: e45674.
30. Pilling, D., T. Fan, D. Huang, B. Kaul, and R. H. Gomer. 2009. Identification of markers that distinguish monocyte-derived fibrocytes from monocytes, macrophages, and fibroblasts. PLoS ONE 4: e7475.
31. Herlihy, S. E., D. Pilling, A. S. Maharjan, and R. H. Gomer. 2013. Dipeptidyl peptidase IV is a human and murine neutrophil chemorepellent. J. Immunol. 190: 6468-6477.
32. Cormier, C. Y., J. G. Park, M. Fiacco, J. Steel, P. Hunter, J. Kramer, R. Singla, and J. LaBaer. 2011. PSI:Biology-materials repository: a biologist's resource for protein expression plasmids. J. Struct. Funct. Genomics 12: 55-62.
33. Witt, A. E., L. M. Hines, N. L. Collins, Y. Hu, R. N. Gunawardane, D. Moreira, J. Raphael, D. Jepson, M. Koundinya, A. Rolfs, et al. 2006. Functional proteomics approach to investigate the biological activities of cDNAs implicated in breast cancer. J. Proteome Res. 5: 599-610.
34. Bang, R., L. Marnell, C. Mold, M. P. Stein, K. T. Clos, C. Chivington-Buck, and T. W. Clos. 2005. Analysis of binding sites in human C-reactive protein for FcgammaRI, FcgammaRIIA, and C1q by site-directed mutagenesis. J. Biol. Chem. 280: 25095-25102.
35. Ruiz-Argüelles, A., and B. Pérez-Romano. 2001. Immunophenotypic analysis of peripheral blood lymphocytes. Curr. Protoc. Cytom. Chapter 6: Unit 6.5.
36. Pilling, D., C. D. Buckley, M. Salmon, and R. H. Gomer. 2003. Inhibition of fibrocyte differentiation by serum amyloid P. J. Immunol. 171: 5537-5546.
37. Crawford, J. R., D. Pilling, and R. H. Gomer. 2010. Improved serum-free culture conditions for spleen-derived murine fibrocytes. J. Immunol. Methods 363: 9-20.
38. Bruhns, P., B. Iannascoli, P. England, D. A. Mancardi, N. Fernandez, S. Jorieux, and M. Daëron. 2009. Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses. Blood 113: 3716-3725.
39. Anthony, R. M., F. Wermeling, and J. V. Ravetch. 2012. Novel roles for the IgG Fc glycan. Ann. N. Y. Acad. Sci. 1253: 170-180.
40. Ravetch, J. V., and B. Perussia. 1989. Alternative membrane forms of Fc gamma RIII(CD16) on human natural killer cells and neutrophils. Cell type-specific expression of two genes that differ in single nucleotide substitutions. J. Exp. Med. 170: 481-497.
41. Maxwell, K. F., M. S. Powell, M. D. Hulett, P. A. Barton, I. F. McKenzie, T. P. Garrett, and P. M. Hogarth. 1999. Crystal structure of the human leukocyte Fc receptor, Fc gammaRIIa. Nat. Struct. Biol. 6: 437-442.
42. van Vugt, M. J., A. F. Heijnen, P. J. Capel, S. Y. Park, C. Ra, T. Saito, J. S. Verbeek, and J. G. Van De Winkel. 1996. FcR gamma-chain is essential for both surface expression and function of human Fc gamma RI (CD64) in vivo. Blood 87: 3593-3599.
43. Shields, R. L., A. K. Namenuk, K. Hong, Y. G. Meng, J. Rae, J. Briggs, D. Xie, J. Lai, A. Stadlen, B. Li, et al. 2001. High resolution mapping of the binding site on human IgG1 for Fc gamma RI, Fc gamma RII, Fc gamma RIII, and FcRn and design of IgG1 variants with improved binding to the Fc gamma R. J. Biol. Chem. 276: 6591-6604.
44. Zhang, W., W. Xu, and S. Xiong. 2011. Macrophage differentiation and polarization via phosphatidylinositol 3-kinase/Akt-ERK signaling pathway conferred by serum amyloid P component. J. Immunol. 187: 1764-1777.
45. Pilling, D., N. M. Tucker, and R. H. Gomer. 2006. Aggregated IgG inhibits the differentiation of human fibrocytes. J. Leukoc. Biol. 79: 1242-1251.
46. Abram, C. L., and C. A. Lowell. 2009. The ins and outs of leukocyte integrin signaling. Annu. Rev. Immunol. 27: 339-362.
47. Kim, M. K., X. Q. Pan, Z. Y. Huang, S. Hunter, P. H. Hwang, Z. K. Indik, and A. D. Schreiber. 2001. Fc gamma receptors differ in their structural requirements for interaction with the tyrosine kinase Syk in the initial steps of signaling for phagocytosis. Clin. Immunol. 98: 125-132.
48. Huang, Z. Y., S. Hunter, M. K. Kim, P. Chien, R. G. Worth, Z. K. Indik, and A. D. Schreiber. 2004. The monocyte Fcgamma receptors FcgammaRI/gamma and FcgammaRIIA differ in their interaction with Syk and with Src-related tyrosine kinases. J. Leukoc. Biol. 76: 491-499.
49. Hunter, S., N. Sato, M. K. Kim, Z. Y. Huang, D. H. Chu, J. G. Park, and A. D. Schreiber. 1999. Structural requirements of Syk kinase for Fcgamma receptor-mediated phagocytosis. Exp. Hematol. 27: 875-884.